CLINICALTRIAL TO STUDY EFFECT OF NAGAKESHARA CHURNA ORALLY WITH VISHNU TAILA UTTARBASTI IN VANDHYATWA(PRIMARY INFERTILITY)

SINGLE ARM CLINICAL TRIAL TO EVALUATE VANDHYATWAHAR PROPERTY OF TRIKATU AND NAGAKESHARA CHURNA ORALLY WITH VISHNU TAILA UTTARBASTI IN VANDHYATWA W.S.R.PRIMARY INFERTILITY - No

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/032646

Enrollment

Registered

2021-04-08

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified

Interventions

Intervention1: Oral drugs and uttarbasti oil: Trikatu and Nagakeshara churna orally with Goghruta Anupana. Vishnu taila uttarbasti. Intervention2: Oral drug and uttarbasti: Trikatu and Nagakeshara ch

Eligibility

Inclusion criteria

Inclusion criteria: Medically treatable primary infertility. 1)Anovulatory cycles 2)PCOD-Oligo ovulation,Anovulation 3)Age group-20-40years 4)BMI-19-30 5)Unexplained infertility 6) Endometriosis-Grade 1 & 2,Without adhesions and chocolate cyst 7)Immunological causes 8)Vandhyatwa(Anapatya-Harita, Sapraja-Charaka)

Exclusion criteria

Exclusion criteria: 1)Secondary infertility 2)Bilateral tubal blockage 3) Endometriosis with chocolate cyst and adhesions 4)Congenital anomalies of uterus and adnexa 5)Husband sterility 6)Age below 20 years and above 40 years 7)Hypothyroidism 8)hyperthyroidism 9)Other major systemic illness 10)Kakvandhya

Design outcomes

Primary

Measure	Time frame
Positive Urine Pregnancy Test and Ultra SonographyTimepoint: 6 months	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactKetaki Dhavale

Yashwant Ayurvedic College P G T &R C

vishalaturlapati@gmail.com9960217429

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026